Drug Profile
Dersalazine
Alternative Names: UR-12746Latest Information Update: 03 Aug 2015
Price :
$50
*
At a glance
- Originator Uriach
- Class Anti-inflammatories; Benzoic acids; Small molecules
- Mechanism of Action Platelet activating factor inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Ulcerative colitis
Highest Development Phases
- Discontinued Ulcerative colitis